These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37131606)

  • 1. Finding the right tool: a comprehensive evaluation of microglial inducible cre mouse models.
    Bedolla A; Mckinsey G; Ware K; Santander N; Arnold T; Luo Y
    bioRxiv; 2023 Apr; ():. PubMed ID: 37131606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of the strengths and potential caveats of the microglial inducible CreER mouse models.
    Bedolla AM; McKinsey GL; Ware K; Santander N; Arnold TD; Luo Y
    Cell Rep; 2024 Jan; 43(1):113660. PubMed ID: 38217856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overlooked subset of Cx3cr1
    Zhou K; Han J; Lund H; Boggavarapu NR; Lauschke VM; Goto S; Cheng H; Wang Y; Tachi A; Xie C; Zhu K; Sun Y; Osman AM; Liang D; Han W; Gemzell-Danielsson K; Betsholtz C; Zhang XM; Zhu C; Enge M; Joseph B; Harris RA; Blomgren K
    J Neuroinflammation; 2022 Jan; 19(1):20. PubMed ID: 35062962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
    Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
    Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of microglial inducible Cre lines.
    Faust TE; Feinberg PA; O'Connor C; Kawaguchi R; Chan A; Strasburger H; Frosch M; Boyle MA; Masuda T; Amann L; Knobeloch KP; Prinz M; Schaefer A; Schafer DP
    Cell Rep; 2023 Sep; 42(9):113031. PubMed ID: 37635351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-independent recombination in the RIP-CreER mouse.
    Liu Y; Suckale J; Masjkur J; Magro MG; Steffen A; Anastassiadis K; Solimena M
    PLoS One; 2010 Oct; 5(10):e13533. PubMed ID: 21063464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-fidelity
    Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
    Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity.
    Zhao XF; Alam MM; Liao Y; Huang T; Mathur R; Zhu X; Huang Y
    eNeuro; 2019; 6(4):. PubMed ID: 31201215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis.
    Han J; Zhu K; Zhou K; Hakim R; Sankavaram SR; Blomgren K; Lund H; Zhang XM; Harris RA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a self-cleaved inducible Cre recombinase for efficient temporal genetic manipulation.
    Tian X; He L; Liu K; Pu W; Zhao H; Li Y; Liu X; Tang M; Sun R; Fei J; Ji Y; Qiao Z; Lui KO; Zhou B
    EMBO J; 2020 Feb; 39(4):e102675. PubMed ID: 31943281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate mapping via CCR2-CreER mice reveals monocyte-to-microglia transition in development and neonatal stroke.
    Chen HR; Sun YY; Chen CW; Kuo YM; Kuan IS; Tiger Li ZR; Short-Miller JC; Smucker MR; Kuan CY
    Sci Adv; 2020 Aug; 6(35):eabb2119. PubMed ID: 32923636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical approach to genetic inducible fate mapping: a visual guide to mark and track cells in vivo.
    Brown A; Brown S; Ellisor D; Hagan N; Normand E; Zervas M
    J Vis Exp; 2009 Dec; (34):. PubMed ID: 20042997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Patterns of Inducible Cre Recombinase Driven by Differential Astrocyte-Specific Promoters in Transgenic Mouse Lines.
    Hu NY; Chen YT; Wang Q; Jie W; Liu YS; You QL; Li ZL; Li XW; Reibel S; Pfrieger FW; Yang JM; Gao TM
    Neurosci Bull; 2020 May; 36(5):530-544. PubMed ID: 31828740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the
    Lesaffer B; Verboven E; Van Huffel L; Moya IM; van Grunsven LA; Leclercq IA; Lemaigre FP; Halder G
    Cells; 2019 Apr; 8(4):. PubMed ID: 31027317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional Deletion of EphA4 on Cx3cr1-Expressing Microglia Fails to Influence Histopathological Outcome and Blood Brain Barrier Disruption Following Brain Injury.
    Soliman E; Mills J; Ju J; Kaloss AM; Basso EKG; Groot N; Kelly C; Kowalski EA; Elhassanny M; Chen M; Wang X; Theus MH
    Front Mol Neurosci; 2021; 14():747770. PubMed ID: 34630039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Cre recombinase  mouse lines enabling cell type-specific targeting of postnatal intervertebral discs.
    Zheng Y; Fu X; Liu Q; Guan S; Liu C; Xiu C; Gong T; Jin H; Saijilafu ; Zhang Z; Chen D; Chen J
    J Cell Physiol; 2019 Sep; 234(9):14422-14431. PubMed ID: 30675722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible Cre mice.
    Feil S; Valtcheva N; Feil R
    Methods Mol Biol; 2009; 530():343-63. PubMed ID: 19266339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cx3Cr1-Cre induction leads to microglial activation and IFN-1 signaling caused by DNA damage in early postnatal brain.
    Sahasrabuddhe V; Ghosh HS
    Cell Rep; 2022 Jan; 38(3):110252. PubMed ID: 35045285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the variables that drive tamoxifen-independent CreERT2 recombination: Implications for microglial fate mapping and gene deletions.
    Van Hove H; Antunes ARP; De Vlaminck K; Scheyltjens I; Van Ginderachter JA; Movahedi K
    Eur J Immunol; 2020 Mar; 50(3):459-463. PubMed ID: 31785096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.